The Administration's Drug Rebate Proposal:
An Opportunity to Put Patients First
February 2019 – The Morning Consult has published an opinion-editorial co-authored by A. Mark Fendrick, MD, V-BID Center Director, and Dan Klein, President & CEO of the PAN Foundation, recommending that patients be the first to benefit from the Trump Administration’s proposal to reallocate rebates paid by drug companies.
To learn more about value-based drug pricing, view the resources below:
